title: 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents.
authors.forename: Donald M
authors.initials: DM
authors.lastname: Lloyd-Jones
authors.forename: Pamela B
authors.initials: PB
authors.lastname: Morris
authors.forename: Christie M
authors.initials: CM
authors.lastname: Ballantyne
authors.forename: Kim K
authors.initials: KK
authors.lastname: Birtcher
authors.forename: David D
authors.initials: DD
authors.lastname: Daly
authors.forename: Sondra M
authors.initials: SM
authors.lastname: DePalma
authors.forename: Margo B
authors.initials: MB
authors.lastname: Minissian
authors.forename: Carl E
authors.initials: CE
authors.lastname: Orringer
authors.forename: Sidney C
authors.initials: SC
authors.lastname: Smith
mesh_terms: D000572:American Heart Association; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D050197:Atherosclerosis / Q000097:blood / Q000188:drug therapy*; D002309:Cardiology; D008078:Cholesterol, LDL / Q000097:blood* / Q000187:drug effects; D032921:Consensus; D003245:Consensus Statements as Topic; D003661:Decision Support Techniques; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology; D014481:United States
chemical_list: D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors
keywords: ACC Expert Consensus Decision Pathway; ASCVD; LDL-C; PCSK9 inhibitors; bile acid sequestrants; cholesterol; dyslipidemia; ezetimibe; lipids; statins